Yeah it seems clear everyone working on this project seems confident. Announcing tumour regression, advancing dosage to 165 mg, stating low toxicity.
Not everyone and their brother will realize this is the real deal until after phase II, however everyone currently following CTIX and K will.
Cohort 7 is a a major milestone. If we successfully make it through cohort 7 without MTD the writing will be on the wall.
K is like a volcano slowly building pressure cohort by cohort...
It won't be long and we'll be back waging war at 2.00, this time we'll win!
Market Data 
Markets 
AI
